Evoke Pharma, Inc.

United States of America

Create a watch for Evoke Pharma, Inc.
Total IP 27
Total IP Rank # 54,924
IP Activity Score 2.2/5.0    18
IP Activity Rank # 46,053
Stock Symbol EVOK (nasdaq)
ISIN US30049G2030
Market Cap. 6.200M  (USD)
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

11 3
5 1
6 0
1
 
Last Patent 2025 - Methods for treating gastroparesis
First Patent 1996 - Nasal administration of agents f...
Last Trademark 2020 - EVOKEASSIST
First Trademark 2011 - EVOKE PHARMA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Methods for treating gastroparesis. Described herein are methods for treating gastroparesis with...
2024 Invention Nasal formulations of metoclopramide. Nasal formulations of metoclopramide, which remain stable ...
2023 Invention Reduction of healthcare resource utilization by patients treated with intranasally-administered m...
Invention Novel methods for treating gastroparesis. Described herein are methods for treating gastroparesis...
2022 Invention Treatment of moderate and severe gastroparesis. Metoclopramide is administered for the treatment ...
2021 Invention Treatment of symptoms associated with female gastroparesis. Nasal formulations of metoclopramide...
Invention Nasal formulations of metoclopramide. Nasal formulations of metoclopramide, which remain stable a...
2020 G/S Counseling for patients, namely providing information with respect to patient pharmaceutical reim...
2019 G/S pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of ga...
2018 Invention Methods of intranasal metoclopramide dosing. The present disclosure relates to methods of intran...
Invention Methods of intranasal metoclopramide dosing. The present disclosure relates to methods of intrana...
2016 G/S Pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of ga...
2012 Invention Treatment of symptoms associated with female gastroparesis. Nasal formulations of metoclopramide ...
2011 G/S Pharmaceutical preparations for the treatment of gastrointestinal diseases Scientific and medical...
2001 Invention Nasal administration of agents for the treatment of gastroparesis. The present invention is direc...
1996 Invention Nasal administration of agents for treatment of delayed onset emesis. The present invention is di...